GlassScriptPhysician profile
Amer M Zeni
NPI 1477709327
$11,311.39
in general payments reported to CMS, 2019-2025
27 companies · $3,205 in 2025
The $3,205 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,637 · 2020: $348 · 2021: $233 · 2022: $698 · 2023: $892 · 2024: $1,299 · 2025: $3,205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,114 · Travel and Lodging: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,114.02 |
| Travel and Lodging | $1,281.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,815.93 | 2019-2022 | |
| Ethicon US, LLC | $2,531.82 | 2019-2025 | Echelon; Endopath, Echelon Circular, Contour |
| Davol INC. | $1,882.85 | 2019-2025 | |
| Medical Device Business Services, INC. | $1,091.46 | 2019 | |
| Tela Bio, INC. | $400.08 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Acera Surgical, INC. | $383.38 | 2024-2025 | Restrata Wound Matrix |
| Medtronic, INC. | $339.78 | 2022-2024 | Interstim, Signia |
| Becton, Dickinson and Company | $191.73 | 2024-2025 | Phasix Mesh |
| Mimedx Group, INC. | $178.49 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $165.82 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $145.09 | 2020-2023 | Entyvio, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.72 | 2019-2024 | Xifaxan, Plenvu |
| Medtronic USA, INC. | $138.81 | 2019 | |
| Covidien LP | $138.13 | 2019 | |
| Braintree Laboratories, INC. | $125.85 | 2019-2024 | Suflave |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $117.31 | 2022-2024 | Axonics |
| Vioptix INC | $101.87 | 2021 | |
| Smith+Nephew, INC. | $81.70 | 2021-2025 | Stravix, Pico 7 |
| Hologic Sales and Service, LLC | $69.23 | 2025 | Coolseal Generator |
| Integra Lifesciences Corporation | $64.52 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $60.08 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $39.39 | 2025 | Puraply Wound Matrix |
| Convatec INC. | $31.01 | 2020 | |
| Innovation Technologies INC | $21.00 | 2019 | |
| Janssen Biotech, INC. | $20.74 | 2025 | Tremfya |
| Laborie Medical Technologies Corp. | $17.32 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $15.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amer Zeni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.